PGIM Jennison Health Sciences Fund- Class C
PHLCX
NASDAQ
| Weiss Ratings | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C+ | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Company Info | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | PGIM Investments | |||
| Manager/Tenure (Years) | Debra Netschert (10), Daniel Matviyenko (4) | |||
| Website | http://www.prudentialfunds.com | |||
| Fund Information | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | PGIM Jennison Health Sciences Fund- Class C | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Jun 30, 1999 | |||
| Open/Closed To New Investors | Closed | |||
| Minimum Initial Investment | 1,000.00 | |||
| Minimum Subsequent Investment | 100.00 | |||
| Front End Fee | -- | |||
| Back End Fee | 0.01 | |||
| Dividends and Shares | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 1.19% | |||
| Dividend | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 0.61% | |||
| Asset Allocation | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 2.27% | |||
| Stock | 97.73% | |||
| U.S. Stock | 80.45% | |||
| Non-U.S. Stock | 17.28% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.06% | |||
| 30-Day Total Return | 6.90% | |||
| 60-Day Total Return | 12.83% | |||
| 90-Day Total Return | 20.81% | |||
| Year to Date Total Return | 18.78% | |||
| 1-Year Total Return | 12.18% | |||
| 2-Year Total Return | 35.10% | |||
| 3-Year Total Return | 41.49% | |||
| 5-Year Total Return | 43.66% | |||
| Price | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $14.86 | |||
| 1-Month Low NAV | $13.67 | |||
| 1-Month High NAV | $15.17 | |||
| 52-Week Low NAV | $10.87 | |||
| 52-Week Low NAV (Date) | Apr 08, 2025 | |||
| 52-Week High NAV | $18.88 | |||
| 52-Week High Price (Date) | Dec 04, 2024 | |||
| Beta / Standard Deviation | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.55 | |||
| Standard Deviation | 14.69 | |||
| Balance Sheet | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 1.56B | |||
| Operating Ratios | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.96% | |||
| Turnover Ratio | 79.00% | |||
| Performance | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 7.98% | |||
| Last Bear Market Total Return | -9.62% | |||